TCL 343 (Caffeine 200 mg)
Pill imprint TCL 343 has been identified as Caffeine 200 mg.
Caffeine is used in the treatment of hypersomnia; apnea of prematurity; asthma and belongs to the drug class CNS stimulants. Caffeine Citrate Injection: Risk cannot be ruled out during pregnancy. Excluding Caffeine Citrate Injection: FDA has not classified the drug for risk during pregnancy. Caffeine 200 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 200 mg
- Rx and/or OTC
N - Not classified - excluding Caffeine Citrate Injection
D&C Yellow No. 10
FD&C Yellow No. 6
hypromellose 2910 (6 mPa.s)
hypromellose 2910 (15 mPa.s)
polyethylene glycol 8000
More about caffeine
- Caffeine Citrate
- Caffeine solution
- Caffeine (Advanced Reading)
- Caffeine Oral, Parenteral (Advanced Reading)
- Caffeine citrate Intravenous (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.